Innovative Psychiatry

Innovative Psychiatry in Columbia, Maryland offers Spravato (esketamine), an FDA-approved nasal spray for treatment-resistant depression. Led by psychiatrist Dr. Anandraj Mattai, the practice provides Spravato for the roughly 30 to 40 percent of patients who do not respond to first-line antidepressants. Many patients report symptom improvement within 24 hours.

Spravato works differently than traditional antidepressants, targeting the NMDA receptor and boosting brain plasticity. Each session is delivered under provider supervision, with a comprehensive consultation and exam before treatment begins, and a ride home arranged afterward.

A multiple-time Top Doctor award winner, Innovative Psychiatry offers Spravato alongside TMS therapy for depression and OCD, medication management, psychotherapy, and GeneSight and T.O.V.A. testing. The practice works with several insurers, including CareFirst BCBS, Cigna, and Johns Hopkins Health Care.